MENU
IMRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immuneering (IMRX) Ownership - Who owns Immuneering?
Profile
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
53.72M
P/E Ratio
N/A
Total Cash
50.66M
Projected Growth
N/A
Total Debt
4.24M
Revenue
N/A
Risk (Beta)
-0.55
Dividend Yield
N/A
Total Cash/Share
1.63
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IMRX
Capitalization
53.7M
P/E Ratio
N/A
Risk (Beta)
-0.55
Dividend Yield
N/A
Total Cash
50.7M
Total Cash/Share
1.63
Total Debt
4.24M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
57.7M
P/B Ratio
0.93
Cash Flow
N/A
Earnings
-1.97
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
31K
Current Ratio
7.99
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-61.58M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-63.66
Shares Held By Institutions
17.7M
Shares Outstanding - Current
31.1M
Total Liabilities
10.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-76.463
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com